All type of patients: 16 trials - LEAD-2 (Nauck) Sulf vs pbo - Inukai - Luis Bautista - Charpentier - Schade - Clark (301) - Sonnenberg - Dills - Draeger - Rosenstock - Study 201 (Goldberg) - Riddle - Kaneko - Charpentier (301F) - Protocol 311 - Study 202
All types of patients: 15 trials - Inukai - Luis Bautista - Charpentier - Schade - Clark (301) - Sonnenberg - Dills - Draeger - Rosenstock - Study 201 (Goldberg) - Riddle - Kaneko - Charpentier (301F) - Protocol 311 - Study 202
Patients inadequately controlled on metformin: 1 trials - Charpentier
Patients inadequately controlled on monotherapy : 3 trials - Inukai - Charpentier - Riddle